Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

GRACE Videos and Articles

LCAM 2015

 

Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.

[powerpress]

[ratingwidget post_id=0]

Check out more LCAM videos & posts here.

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation